✉news TechnologyAI first seen 6 d ago, last 6 d ago, peak #11
AstraZeneca partners with insitro on AI drug discovery
Original: AstraZeneca announces new strategic collaboration with insitro to use advanced AI systems to develop transformative therapeutics for difficult to treat cardiometabolic diseases
AstraZeneca has announced a strategic collaboration with AI-driven drug discovery company insitro to develop new treatments for cardiometabolic diseases that are difficult to treat. The partnership will use advanced machine learning systems to identify and design transformative therapeutics. The move reflects the pharmaceutical industry's growing reliance on artificial intelligence to speed up drug development and tackle conditions with high unmet medical need.
Why now: A major pharmaceutical company is adopting AI for drug discovery, a topic of strong current interest.
Evidence
API: https://socialmediatrends-api.osmike.com/v1/trends/2369726